The infusion rate of mivacurium and its spontaneous neuromuscular recovery in magnesium-treated parturients

Anesthesia and Analgesia

Volumn 86, Issue 3, 1998, Pages 523-526

  Ahn, Eun Kyoung ^a   Bai, Sun Joon ^a   Cho, Bum Joon ^a   Shin, Yang Sik ^a  

^a Yonsei University College of Medicine   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

ENFLURANE; FENTANYL; GLYCOPYRRONIUM BROMIDE; MAGNESIUM; MAGNESIUM SULFATE; MIDAZOLAM; MIVACURIUM; NEUROMUSCULAR BLOCKING AGENT; NITROUS OXIDE; PYRIDOSTIGMINE; SUXAMETHONIUM; THIOPENTAL;

ANESTHETIC RECOVERY; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED STUDY; DRUG INFUSION; ELECTROMYOGRAPHY; FEMALE; GENERAL ANESTHESIA; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MAGNESIUM BLOOD LEVEL; NEUROMUSCULAR BLOCKING; PREECLAMPSIA; PRIORITY JOURNAL;

CHOLINESTERASES; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG INTERACTIONS; FEMALE; HUMANS; ISOQUINOLINES; MAGNESIUM; NEUROMUSCULAR JUNCTION; NEUROMUSCULAR NONDEPOLARIZING AGENTS; PRE-ECLAMPSIA; PREGNANCY; SUCCINYLCHOLINE; SYNAPTIC TRANSMISSION; TIME FACTORS;

EID: 0242672433     PISSN: 00032999     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000539-199803000-00014     Document Type: Article

References (15)

1. Sinatra RS, Philip BK, Naulty JS, et al. Prolonged neuromuscular blockade with vecuronium in a patient treated with magnesium sulfate. Anesth Analg 1985;64:1220-2.
2. Fuchs-Buder T, Wilder-Smith OH, Borgeat A, et al. Interaction of magnesium sulfate with vecuronium-induced neuromuscular block. Br J Anaesth 1995;74:405-9.
3. Savarese JJ, Ali HH, Salvatore JB, et al. The clinical neuromuscular pharmacology of mivacurium chloride (BW B1090U). Anesthesiology 1988;58:723-32.
4. Cook DR, Stiller RL, Weakly JN, et al. In vitro metabolism of mivacurium chloride (BW B1090U) and succinylcholine. Anesth Analg 1989;68:452-6.
5. Jan GSK, Tong WN, Chan AMH, et al. Recovery from mivacurium block with or without anticholinesterase following continuous infusion in obstetric patients. Anaesthesiol Intensive Care 1996;24:585-9.
6. Hart PS, McCarthy GJ, Brown R, et al. The effect of plasma cholinesterase activity on mivacurium infusion rates. Anesth Analg 1995;80:760-3.
7. Deleted in proof.
8. Ghoneim MM, Long JB. The interaction between magnesium and other neuromuscular blocking agents. Anesthesiology 1970; 32:23-7.
9. Del Castillo J, Engback L. The nature of neuromuscular block produced by magnesium. J Physiol (Lond) 1945;124:370-84.
10. Anis B, Alex Y. Neuromuscular interaction of magnesium with succinylcholine-vecuronium sequence in the eclamptic parturi-ent. Anesthesiology 1987;67:806-8.
11. Ostergaard D, Jensen FS, Jensen E, et al. Influence of plasma cholinesterase activity on recovery from mivacurium-induced neuromuscular blockade in phenotypically normal patients. Acta Anaesthesiol Scand 1992;36:702-6.
12. Cook DR, Freeman JA, Lai AA, et al. Pharmacokinetics of mivacurium in normal patients and in those with hepatic or renal failure. Br J Anaesth 1992;69:580-5.
13. Skaredoff MN, Roaf ER, Datta S. Hypermagnesaemia and anaesthetic management. Can Anaesth Soc J 1982;29:35-41.
14. Baraka A, Yazigi A. Neuromuscular interaction of magnesium with succinylcholine-vecuronium sequence in the eclamptic parturient. Anesthesiology 1987;67:806-8.
15. James MFM, Cork RC, Dennett JE. Succinylcholine pretreatment with magnesium sulfate. Anesth Analg 1986;65:373-6.